Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – MUSC and Bristol-Myers Squibb Announce Translational Research Collaboration Focused on Fibrotic Diseases

[Business Wire] – The Medical University of South Carolina and Bristol-Myers Squibb Company today announced that they have entered into a translational research collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and . . . → Read More: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – MUSC and Bristol-Myers Squibb Announce Translational Research Collaboration Focused on Fibrotic Diseases Similar Articles: Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer Market Update (NYSE:BMY): Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen Market Update (NYSE:BMY): Bristol-Myers Squibb Announces Cash Tender Offer For Up to $400 Million Aggregate Principal Amount of its Outstanding Debt Securities